HMP 501 Designing Clinical Trial Treatment or Vaccine
I don’t know how to handle this Health & Medical question and need guidance.
Randomized controlled trials are typically considered to be the gold standard of clinical research. However, when research is conducted during an emergency, alternative trial designs might be more appropriate, for example, a design in which every participant receives the experimental treatment or vaccine, in the hope that it will provide some benefit. What ethical considerations are relevant to designing a clinical trial of a treatment or vaccine in the midst of the COVID-19 pandemic?
Assessment of Acute Kidney Rejection Abstract
I need support with this Health & Medical question so I can learn better.
Research abstract for an ongoing project It is called assessment of acute kidney rejection using urinary and plasma signatures in Saudi patients.
abstract for an ongoing research project it is called assessment of acute kidney rejection using urinary and plasma signatures in Saudi transplant patients. So the total of patient right now 140- 2 years so far but the research is 5 years and looking for 450 patients. What we have done so far we collected blood and urine from patients ( we did not take saliva so far- it was meant for babes that if we cannot take blood we can extract DNA or RNA from the saliva). There are different project under this 1- with the proteomics ( the department of proteomics took the plasma after we did PBMCs test to separate the blood. ) 2- genetics ( they took DNA to run Exome known as whole genome sequencing and axiom tests for “ The Saudi genome project”. 3- RNA for gene expressions 4- urine both RNA and Urine were collected and they will be send to one collaborator in US. Part of the paper we are looking for is the history of the family so we wrote a map on a board “ see the picture”. So we contacted with the patient or went to their hospital history to find the info that was written in the board . S